391 related articles for article (PubMed ID: 26658997)
1. Insights into the Role of microRNAs in Pancreatic Cancer Pathogenesis: Potential for Diagnosis, Prognosis, and Therapy.
Khan MA; Zubair H; Srivastava SK; Singh S; Singh AP
Adv Exp Med Biol; 2015; 889():71-87. PubMed ID: 26658997
[TBL] [Abstract][Full Text] [Related]
2. Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer.
Rachagani S; Macha MA; Heimann N; Seshacharyulu P; Haridas D; Chugh S; Batra SK
Adv Drug Deliv Rev; 2015 Jan; 81():16-33. PubMed ID: 25453266
[TBL] [Abstract][Full Text] [Related]
3. The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer.
Xiong G; Feng M; Yang G; Zheng S; Song X; Cao Z; You L; Zheng L; Hu Y; Zhang T; Zhao Y
Cancer Lett; 2017 Jul; 397():94-102. PubMed ID: 28254409
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs as biomarkers and perspectives in the therapy of pancreatic cancer.
Xia T; Chen XY; Zhang YN
Mol Cell Biochem; 2021 Dec; 476(12):4191-4203. PubMed ID: 34324119
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs in Pancreatic Cancer: biomarkers, prognostic, and therapeutic modulators.
Daoud AZ; Mulholland EJ; Cole G; McCarthy HO
BMC Cancer; 2019 Nov; 19(1):1130. PubMed ID: 31752758
[TBL] [Abstract][Full Text] [Related]
6. Investigating the regulatory role of miRNAs as silent conductors in the management of pathogenesis and therapeutic resistance of pancreatic cancer.
Abulsoud AI; Elshaer SS; Abdelmaksoud NM; Zaki MB; El-Mahdy HA; Ismail A; Al-Noshokaty TM; Fathi D; Abdel-Reheim MA; Mohammed OA; Doghish AS
Pathol Res Pract; 2023 Nov; 251():154855. PubMed ID: 37806169
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of key microRNAs in pancreatic cancer development.
Baradaran B; Shahbazi R; Khordadmehr M
Biomed Pharmacother; 2019 Jan; 109():1008-1015. PubMed ID: 30551350
[TBL] [Abstract][Full Text] [Related]
8. Noncoding RNAs and pancreatic cancer.
Peng JF; Zhuang YY; Huang FT; Zhang SN
World J Gastroenterol; 2016 Jan; 22(2):801-14. PubMed ID: 26811626
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA in Pancreatic Cancer: From Biology to Therapeutic Potential.
Rawat M; Kadian K; Gupta Y; Kumar A; Chain PSG; Kovbasnjuk O; Kumar S; Parasher G
Genes (Basel); 2019 Sep; 10(10):. PubMed ID: 31557962
[TBL] [Abstract][Full Text] [Related]
10. Targeting microRNAs in pancreatic cancer: microplayers in the big game.
Khan S; Ansarullah ; Kumar D; Jaggi M; Chauhan SC
Cancer Res; 2013 Nov; 73(22):6541-7. PubMed ID: 24204026
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs in pancreatic malignancy: progress and promises.
Srivastava SK; Arora S; Singh S; Bhardwaj A; Averett C; Singh AP
Cancer Lett; 2014 Jun; 347(2):167-74. PubMed ID: 24561061
[TBL] [Abstract][Full Text] [Related]
12. Noncoding RNAs as novel biomarkers in pancreatic cancer: what do we know?
Previdi MC; Carotenuto P; Zito D; Pandolfo R; Braconi C
Future Oncol; 2017 Feb; 13(5):443-453. PubMed ID: 27841659
[TBL] [Abstract][Full Text] [Related]
13. Emerging roles of microRNAs in pancreatic cancer diagnosis, therapy and prognosis (Review).
Subramani R; Gangwani L; Nandy SB; Arumugam A; Chattopadhyay M; Lakshmanaswamy R
Int J Oncol; 2015 Oct; 47(4):1203-10. PubMed ID: 26314882
[TBL] [Abstract][Full Text] [Related]
14. Sweating the small stuff: microRNAs and genetic changes define pancreatic cancer.
Tang S; Bonaroti J; Unlu S; Liang X; Tang D; Zeh HJ; Lotze MT
Pancreas; 2013 Jul; 42(5):740-59. PubMed ID: 23774697
[TBL] [Abstract][Full Text] [Related]
15. New avenues in pancreatic cancer: exploiting microRNAs as predictive biomarkers and new approaches to target aberrant metabolism.
Capula M; Mantini G; Funel N; Giovannetti E
Expert Rev Clin Pharmacol; 2019 Dec; 12(12):1081-1090. PubMed ID: 31721608
[No Abstract] [Full Text] [Related]
16. MicroRNA-196b is an independent prognostic biomarker in patients with pancreatic cancer.
Kanno S; Nosho K; Ishigami K; Yamamoto I; Koide H; Kurihara H; Mitsuhashi K; Shitani M; Motoya M; Sasaki S; Tanuma T; Maguchi H; Hasegawa T; Kimura Y; Takemasa I; Shinomura Y; Nakase H
Carcinogenesis; 2017 Apr; 38(4):425-431. PubMed ID: 28186267
[TBL] [Abstract][Full Text] [Related]
17. Roles and mechanisms of microRNAs in pancreatic cancer.
Zhang L; Jamaluddin MS; Weakley SM; Yao Q; Chen C
World J Surg; 2011 Aug; 35(8):1725-31. PubMed ID: 21222121
[TBL] [Abstract][Full Text] [Related]
18. Targeting miRNAs for pancreatic cancer therapy.
Shi M; Xie D; Gaod Y; Xie K
Curr Pharm Des; 2014; 20(33):5279-86. PubMed ID: 24479803
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial DNA and MitomiR Variations in Pancreatic Cancer: Potential Diagnostic and Prognostic Biomarkers.
Moro L
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575852
[TBL] [Abstract][Full Text] [Related]
20. Downregulated miR-506 expression facilitates pancreatic cancer progression and chemoresistance via SPHK1/Akt/NF-κB signaling.
Li J; Wu H; Li W; Yin L; Guo S; Xu X; Ouyang Y; Zhao Z; Liu S; Tian Y; Tian Z; Ju J; Ni B; Wang H
Oncogene; 2016 Oct; 35(42):5501-5514. PubMed ID: 27065335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
